Back to search results

Patient Preference for Subcutaneous vs. Intravenous Immune Therapy

Abroad (travel likely)RecruitingPHASE2

Conditions

Renal Cell Carcinoma · Non Small Cell Lung Cancer · Melanoma · Colo-rectal Cancer (dMMR/MSI-H CRC) · Hepatocellular Carcinoma · Ulcerative Colitis · Esophageal Cancer · Squamous Cell Carcinoma · Gastric/GEJ · Cervical Cancer · Gastro-Esophageal Adenocarcinoma · Esophageal Adenocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Danielle L Bednarz, RN) · bednarzdl@upmc.edu · 4126231191
    Contact: Study coordinator (Amy Rose, RN) · kennaj@upmc.edu · 4126478587
    Contact: Principal Investigator (Diwakar J Davar, MD)
Study leads

  • Diwakar J Davar, MD

    Principal Investigator

    UPMC Hillman Cancer Center

View source on ClinicalTrials.gov(opens in a new tab)